Osama Khan: A federal court has struck down the FDA’s attempt to regulate Laboratory-Developed Tests

Elvina Almuradova: The recent FDA approval of larotrectinib reminds that NTRK fusions can occur across many tumor types

U.S. FDA grants full approval of VITRAKVI – LUNGevity Foundation

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Michael Sapienza: FDA Approves Nivolumab/Ipilimumab for Colorectal Cancer

Miguel Bronchud: Rare Cancers in Special Situations can also be treated with targeted oral therapies

Yan Leyfman: What happens when cancer drugs lose FDA approval for an indication?

Garrett M. Brodeur: PEEL-224 will serve as a prototype for the development of future nanomedicines

Can Joe Lonsdale Become the Elon Musk of FDA Reform?

Yelak Biru: Phase 3 trials supporting FDA approvals in myeloma